25 March 2025

What Science Can Do: New story alert

Cardiovascular, renal and metabolism (CVRM) diseases are a major global health challenge, with significant patient and economic impact. AstraZeneca is working to transform patient care for millions by building one of the broadest, most innovative CVRM pipelines.

Our ambition is to detect, diagnose and treat people earlier and more effectively, working to enhance patient outcomes and improve quality of life.

Together, we can make a difference.

Read more